TerminatedNot Applicable

World Health Organization Disability Assessment Schedule II (WHODAS-II) for Patients With Symptomatic Lumbar Spinal Stenosis

Stopped: Recruitment was so slow, that it made the study impossible. Organizational changes made it impossible for recruiting centers to continue recruitment

Spain200 participantsStarted 2007-04

Plain-language summary

The main purpose of this study is to determine the measurement characteristics of WHODAS-II (World Health Organization Disability Assessment Schedule II), as well as to analyze its correlation with symptomatic lumbar spinal stenosis (Visual Analog Scale, VAS), disability (Spanish version of the Roland Morris Questionnaire, RMQ), fear avoidance beliefs and attitudes (Spanish version of the FAB Questionnaire, FABQ), and quality of life (SF-12). Measurements will be taken at baseline and 6 days later (day 7).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients seen for symptomatic lumbar spinal stenosis * With signs of neurogenous claudication * MRI or CAT scan concordant with observed signs * Able to read and write * Have signed the informed consent form Exclusion Criteria: * Central nervous system pathology (with or without treatment) * Diagnosis of rheumatic inflammatory disease or fibromyalgia * Red flags for underlying systemic disease * Criteria for diagnosis of disc herniation * Symptoms suggesting saddle anesthesia, cauda equina, loss of sphincter tone or paraparesis * Motor deficit that progresses or does not improve in 6 weeks

What they're measuring

Measurement characteristics of WHODAS-II

Timeframe: At baseline and at 7 days

Trial details

NCT IDNCT00480311

SponsorKovacs Foundation

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2011-04

View on ClinicalTrials.gov More Lumbar Spinal Stenosis trials